Artículos del autor

solaci

Day 1

ODYSSEYCOMBO II: Alirocumab more effective than ezetimibe when statins are insufficient

The aim of the study was to show a reduction in LDL cholesterol with the use of...
solaci -
Day 1

SIGNIFY: Ivabradine does not reduce events in patients with stable coronary disease

The increase in heart rate in the setting of chronic coronary artery disease is associated with poor...
solaci -
Day 1

ODYSSEY FH I and FH II: Alirocumab in patients with heterozygous familial hypercholesterolemia

The study included patients with a diagnosis of heterozygous familial hypercholesterolemia who were receiving the maximum tolerated...
solaci -
Day 1

LISTEN: Rosuvastatin versus atorvastatin in Japanese diabetic patients

The treatment of hyperlipidemia is useful in primary and secondary prevention of chronic heart disease and stroke,...
solaci -
Day 4

EXCITE ISR: Excimer laser versus balloon angioplasty for stent restenosis of the superficial femoral

This multicenter, prospective, randomized trial compared the Excimer laser atherectomy (Excimer Laser Atherectomy = ELA, Spectranetics, Inc.)...
solaci -
Day 4

EVERBIO II: Bio-absorbable stent Absorb versus everolimus-eluting or biolimus stents

The new generation drug-eluting everolimus or biolimus stents have proved superior to the first generation. However, neo...
solaci -
Day 4

TAVR: Study comparing cardiac magnetic resonance versus transthoracic echocardiography to assess and quantify aortic regurgitation in patients undergoing TAVI

Henrique Ribeiro2014-09-17
solaci -
Day 4

INOVARE VALVE: Braile prosthesis for the treatment of transapical aortic stenosis

Diego Gaia2014-09-17
solaci -